1、2 0 2 2 A N N U A L R E P O R TD A N A H E R|2 0 2 2 A N N U A L R E P O R TOUTSIDE COVERFINANCIAL OPERATING HIGHLIGHTS(DOLLARS IN MILLIONS EXCEPT PER SHARE DATA AND NUMBER OF ASSOCIATES)*Long-Term Debt($9,086 for 2022 and$22,168 for 2021)plus Notes Payable and Current Portion of Long-Term Debt($591
2、 for 2022 and$8 for 2021)All financial data set forth in this annual report relates solely to continuing operations unless otherwise indicated.20222021Sales$31,471$,Operating Profit$8,688$,Net Earnings$7,209$,Net Earnings Per Common Share (diluted)$9.66$8.Operating Cash Flow$8,519$8,8Investing Cash
3、Flow$(2,234)$(1,8)Financing Cash Flow$(2,570)$1,Capital Expenditures$(1,152)$(1,)Capital Disposals$9$1Free Cash Flow (Operating Cash Flow less Capital Expenditures plus Capital Disposals)$7,376$,Number of Associates81,0008,Total Assets$84,350$8,1Total Debt*$19,677$,1Stockholders Equity$50,090$,1Tota
4、l Capitalization (Total Debt plus Stockholders Equity)$69,767$,2022 SEGMENT REVENUESLIFE SCIENCESBIOTECHNOLOGY$7.0B$8.8BDIAGNOSTICS$10.8BENVIRONMENTAL&APPLIED SOLUTIONS$4.8B 60%Recurring 40%Nonrecurring 45%North America 20%Western Europe 28%High-Growth Markets 7%Other Developed MarketsMIXGEO 79%Recu
5、rring 21%Nonrecurring 35%North America 30%Western Europe 31%High-Growth Markets 4%Other Developed MarketsMIXGEO 89%Recurring 11%Nonrecurring 51%North America 17%Western Europe 28%High-Growth Markets 4%Other Developed MarketsMIXGEO 59%Recurring 41%Nonrecurring 46%North America 22%Western Europe 29%Hi
6、gh-Growth Markets 3%Other Developed MarketsMIXGEOAll pie charts represent total 2022 revenue.DEAR SHAREHOLDERS,2022 SHAREHOLDER LETTER2022 was another terrific year for Danaher.We leveraged the power of the Danaher Business System(DBS)to deliver outstanding core revenue and earnings growth and stron